What changed?
A sourced timeline of research records and material development changes tracked by BACToBasics for MariTide. Research-publication dates and clinical-development event dates are labeled separately so they are not mistaken for the same type of update.
Tracked items
1
Research sources
0
Development entries
1
Latest recorded date
Nov 4, 2025
Latest development activity
Nov 4, 2025 · Program status · Phase 3
Amgen reported completed enrollment in its two core chronic-weight-management Phase 3 trials while additional cardiovascular, heart-failure, and sleep-apnea studies continued.
Open source ↗Tracked timeline
Development changes are dated to the underlying milestone. Research-source entries use the study or source publication year currently stored in the Research Library; that year is not presented as the date BACToBasics added the record.
Program status · Phase 3
Amgen reported completed enrollment in its two core chronic-weight-management Phase 3 trials while additional cardiovascular, heart-failure, and sleep-apnea studies continued.
Following a compound creates a clean baseline from the updates currently known. When BACToBasics later records a new research source or material development change, the My Tools update badge can surface it as new for you.
BACToBasics provides educational research organization only. A development milestone does not predict future approval, and a research record does not establish that a compound is safe, effective, approved, or appropriate for use.